The Impact of Frailty on Thrombosis of Elderly Patients With Non-valvular Atrial Fibrillation (NVAF).
试验速览
- 阶段
- 不适用
- 入组人数
- 500
- 试验地点
- 1
- 主要终点
- Ischemic stroke
研究概览
简要总结
This study aims to investigate the use of anticoagulants in elderly patients with non-valvular atrial fibrillation (NVAF) and the incidence of frailty in elderly patients with NVAF. After two years follow-up, we observe the incidence of thrombotic events and the influence of frailty on thrombotic events in elderly patients with NVAF.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 65 Years 至 —(Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Confirmed non-valvular atrial fibrillation (NVAF) diagnosis with ECG or Holter
- •fulfilled CHA2DS2-VASc, HAS-BLED and Fried Scale
- •patients agreed and provided informed consent
排除标准
- •valvular atrial fibrillation
- •cardiac surgery related atrial fibrillation
- •acute disease related atrial fibrillation
- •patients not fulfilled all the exam and text,or not accept the follow-up
结局指标
主要结局
Ischemic stroke
时间窗: 24 months
Cerebral infarction, Transient ischemic attack, Cerebral embolism.
Massive hemorrhage
时间窗: 24 months
Life-threatening or imminently fatal bleeding, intracranial, retroperitoneal, compartment syndrome, massive gastrointestinal, etc.
All-cause death
时间窗: 24 months
All-cause death during the 2-year observation
次要结局
未报告次要终点
研究者
Hongwei Li, MD
Prof.
Beijing Friendship Hospital
